172 related articles for article (PubMed ID: 21785893)
1. Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences.
Li Q; Guo Y; Ou Q; Wu WJ; Chen N; Zhu X; Tan W; Yuan F; Dawn B; Luo L; Hunt GN; Bolli R
Basic Res Cardiol; 2011 Nov; 106(6):1367-77. PubMed ID: 21785893
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences.
Li Q; Guo Y; Wu WJ; Ou Q; Zhu X; Tan W; Yuan F; Chen N; Dawn B; Luo L; O'Brien E; Bolli R
Basic Res Cardiol; 2011 Nov; 106(6):1355-66. PubMed ID: 21779912
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences.
Li Q; Guo Y; Tan W; Stein AB; Dawn B; Wu WJ; Zhu X; Lu X; Xu X; Siddiqui T; Tiwari S; Bolli R
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H584-9. PubMed ID: 16172153
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.
Melo LG; Agrawal R; Zhang L; Rezvani M; Mangi AA; Ehsan A; Griese DP; Dell'Acqua G; Mann MJ; Oyama J; Yet SF; Layne MD; Perrella MA; Dzau VJ
Circulation; 2002 Feb; 105(5):602-7. PubMed ID: 11827926
[TBL] [Abstract][Full Text] [Related]
5. Heme Oxygenase-1 Gene Therapy Provides Cardioprotection Via Control of Post-Ischemic Inflammation: An Experimental Study in a Pre-Clinical Pig Model.
Hinkel R; Lange P; Petersen B; Gottlieb E; Ng JK; Finger S; Horstkotte J; Lee S; Thormann M; Knorr M; El-Aouni C; Boekstegers P; Reichart B; Wenzel P; Niemann H; Kupatt C
J Am Coll Cardiol; 2015 Jul; 66(2):154-65. PubMed ID: 26160631
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway.
Li Q; Guo Y; Ou Q; Cui C; Wu WJ; Tan W; Zhu X; Lanceta LB; Sanganalmath SK; Dawn B; Shinmura K; Rokosh GD; Wang S; Bolli R
Circulation; 2009 Sep; 120(13):1222-30. PubMed ID: 19752329
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function.
Liu X; Pachori AS; Ward CA; Davis JP; Gnecchi M; Kong D; Zhang L; Murduck J; Yet SF; Perrella MA; Pratt RE; Dzau VJ; Melo LG
FASEB J; 2006 Feb; 20(2):207-16. PubMed ID: 16449792
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of IkappaBalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury.
Squadrito F; Deodato B; Squadrito G; Seminara P; Passaniti M; Venuti FS; Giacca M; Minutoli L; Adamo EB; Bellomo M; Marini R; Galeano M; Marini H; Altavilla D
Lab Invest; 2003 Aug; 83(8):1097-104. PubMed ID: 12920239
[TBL] [Abstract][Full Text] [Related]
9. Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction.
Liu X; Simpson JA; Brunt KR; Ward CA; Hall SR; Kinobe RT; Barrette V; Tse MY; Pang SC; Pachori AS; Dzau VJ; Ogunyankin KO; Melo LG
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H48-59. PubMed ID: 17322421
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
Li Q; Guo Y; Xuan YT; Lowenstein CJ; Stevenson SC; Prabhu SD; Wu WJ; Zhu Y; Bolli R
Circ Res; 2003 Apr; 92(7):741-8. PubMed ID: 12702642
[TBL] [Abstract][Full Text] [Related]
11. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury.
Wojakowski W; Tendera M; Cybulski W; Zuba-Surma EK; Szade K; Florczyk U; Kozakowska M; Szymula A; Krzych L; Paslawska U; Paslawski R; Milewski K; Buszman PP; Nabialek E; Kuczmik W; Janiszewski A; Dziegiel P; Buszman PE; Józkowicz A; Dulak J
Thromb Haemost; 2012 Sep; 108(3):464-75. PubMed ID: 22872040
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.
Li Q; Guo Y; Tan W; Ou Q; Wu WJ; Sturza D; Dawn B; Hunt G; Cui C; Bolli R
Circulation; 2007 Oct; 116(14):1577-84. PubMed ID: 17785622
[TBL] [Abstract][Full Text] [Related]
13. A vigilant, hypoxia-regulated heme oxygenase-1 gene vector in the heart limits cardiac injury after ischemia-reperfusion in vivo.
Tang YL; Qian K; Zhang YC; Shen L; Phillips MI
J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):251-63. PubMed ID: 16382261
[TBL] [Abstract][Full Text] [Related]
14. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
Prasad KM; Smith RS; Xu Y; French BA
J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
[TBL] [Abstract][Full Text] [Related]
15. Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
Penumathsa SV; Koneru S; Zhan L; John S; Menon VP; Prasad K; Maulik N
J Mol Cell Cardiol; 2008 Jan; 44(1):170-9. PubMed ID: 18001768
[TBL] [Abstract][Full Text] [Related]
16. [Effect of heme oxygenase-1 expression and activity on the heart function in ischemia-reperfusion].
Kukoba TV; Kotsiuruba AV; Moĭbenko OO
Fiziol Zh (1994); 2006; 52(1):41-8. PubMed ID: 16553297
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction.
Mohan IK; Khan M; Wisel S; Selvendiran K; Sridhar A; Carnes CA; Bognar B; Kálai T; Hideg K; Kuppusamy P
Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H140-51. PubMed ID: 18978191
[TBL] [Abstract][Full Text] [Related]
18. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.
Galeano M; Deodato B; Altavilla D; Squadrito G; Seminara P; Marini H; Stagno d'Alcontres F; Colonna M; Calò M; Lo Cascio P; Torre V; Giacca M; Venuti FS; Squadrito F
Crit Care Med; 2003 Apr; 31(4):1017-25. PubMed ID: 12682466
[TBL] [Abstract][Full Text] [Related]
20. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice.
Liu X; Wei J; Peng DH; Layne MD; Yet SF
Diabetes; 2005 Mar; 54(3):778-84. PubMed ID: 15734856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
